Literature DB >> 28887351

Using predictive analytics and big data to optimize pharmaceutical outcomes.

Inmaculada Hernandez1, Yuting Zhang2.   

Abstract

PURPOSE: The steps involved, the resources needed, and the challenges associated with applying predictive analytics in healthcare are described, with a review of successful applications of predictive analytics in implementing population health management interventions that target medication-related patient outcomes.
SUMMARY: In healthcare, the term big data typically refers to large quantities of electronic health record, administrative claims, and clinical trial data as well as data collected from smartphone applications, wearable devices, social media, and personal genomics services; predictive analytics refers to innovative methods of analysis developed to overcome challenges associated with big data, including a variety of statistical techniques ranging from predictive modeling to machine learning to data mining. Predictive analytics using big data have been applied successfully in several areas of medication management, such as in the identification of complex patients or those at highest risk for medication noncompliance or adverse effects. Because predictive analytics can be used in predicting different outcomes, they can provide pharmacists with a better understanding of the risks for specific medication-related problems that each patient faces. This information will enable pharmacists to deliver interventions tailored to patients' needs. In order to take full advantage of these benefits, however, clinicians will have to understand the basics of big data and predictive analytics.
CONCLUSION: Predictive analytics that leverage big data will become an indispensable tool for clinicians in mapping interventions and improving patient outcomes.
Copyright © 2017 by the American Society of Health-System Pharmacists, Inc. All rights reserved.

Entities:  

Keywords:  big data; medication management; pharmaceutical outcomes; population health management; predictive analytics

Mesh:

Substances:

Year:  2017        PMID: 28887351     DOI: 10.2146/ajhp161011

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN: 1079-2082            Impact factor:   2.637


  8 in total

1.  Risk Factors for Cardiovascular Events in Patients on Antidementia Medications.

Authors:  Meiqi He; James M Stevenson; Yuting Zhang; Inmaculada Hernandez
Journal:  Am J Alzheimers Dis Other Demen       Date:  2020 Jan-Dec       Impact factor: 2.035

2.  How can Big Data Analytics Support People-Centred and Integrated Health Services: A Scoping Review.

Authors:  Timo Schulte; Sabine Bohnet-Joschko
Journal:  Int J Integr Care       Date:  2022-06-16       Impact factor: 2.913

3.  A Model to Predict Risk of Hyperkalemia in Patients with Chronic Kidney Disease Using a Large Administrative Claims Database.

Authors:  Ajay Sharma; Paula J Alvarez; Steven D Woods; Dingwei Dai
Journal:  Clinicoecon Outcomes Res       Date:  2020-11-09

Review 4.  Big Data and Atrial Fibrillation: Current Understanding and New Opportunities.

Authors:  Qian-Chen Wang; Zhen-Yu Wang
Journal:  J Cardiovasc Transl Res       Date:  2020-05-06       Impact factor: 4.132

5.  Application of Big Data to Support Evidence-Based Public Health Policy Decision-Making for Hearing.

Authors:  Gabrielle H Saunders; Jeppe H Christensen; Johanna Gutenberg; Niels H Pontoppidan; Andrew Smith; George Spanoudakis; Doris-Eva Bamiou
Journal:  Ear Hear       Date:  2020 Sep/Oct       Impact factor: 3.562

6.  Using Machine Learning to Predict Early Preparation of Pharmacy Prescriptions at PSMMC - a Comparison of Four Machine Learning Algorithms.

Authors:  Nora Alhorishi; Mohammed Almeziny; Riyad Alshammari
Journal:  Acta Inform Med       Date:  2021-03

Review 7.  A Review of the Role and Challenges of Big Data in Healthcare Informatics and Analytics.

Authors:  Banan Jamil Awrahman; Chia Aziz Fatah; Mzhda Yasin Hamaamin
Journal:  Comput Intell Neurosci       Date:  2022-09-29

8.  The intersection of genomics and big data with public health: Opportunities for precision public health.

Authors:  Muin J Khoury; Gregory L Armstrong; Rebecca E Bunnell; Juliana Cyril; Michael F Iademarco
Journal:  PLoS Med       Date:  2020-10-29       Impact factor: 11.069

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.